Australian Pharmaceutical Industries Ltd
ASX:API

Watchlist Manager
Australian Pharmaceutical Industries Ltd Logo
Australian Pharmaceutical Industries Ltd
ASX:API
Watchlist
Price: 1.53 AUD Market Closed
Market Cap: AU$753.8m

Australian Pharmaceutical Industries Ltd
Short-Term Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Australian Pharmaceutical Industries Ltd
Short-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Australian Pharmaceutical Industries Ltd
ASX:API
Short-Term Debt
AU$20.9m
CAGR 3-Years
120%
CAGR 5-Years
70%
CAGR 10-Years
N/A
Paragon Care Ltd
ASX:PGC
Short-Term Debt
AU$11.9m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sigma Healthcare Ltd
ASX:SIG
Short-Term Debt
AU$35.5m
CAGR 3-Years
113%
CAGR 5-Years
-12%
CAGR 10-Years
-7%
No Stocks Found

Australian Pharmaceutical Industries Ltd
Glance View

Market Cap
753.8m AUD
Industry
Health Care

Australian Pharmaceutical Industries Ltd. engages in the wholesale, product delivery, retail services, marketing programs and business advisory services. The company is headquartered in Melbourne, Victoria. The Company’s segments include Australia and New Zealand. The Australia segment is engaged in distribution of pharmaceutical, medical, health, beauty and lifestyle products and retail services to pharmacies, the purchase and sale of health, beauty and lifestyle products and services within the retail industry, including cosmetic products and non-invasive procedures. The New Zealand segment manufactures and owns rights for pharmaceutical medicines and consumer toiletries. The firm's brands include Priceline & Priceline Pharmacy, which is a health, beauty and wellbeing retailer; Soul Pattinson Chemist, which is a pharmacy brand; Pharmacist Advice, which offers professional service and advice; Club Premium, which is a club for independent pharmacies, and Pharmacy Best Buys, which offers a catalog program.

API Intrinsic Value
Not Available

See Also

What is Australian Pharmaceutical Industries Ltd's Short-Term Debt?
Short-Term Debt
20.9m AUD

Based on the financial report for Aug 31, 2021, Australian Pharmaceutical Industries Ltd's Short-Term Debt amounts to 20.9m AUD.

What is Australian Pharmaceutical Industries Ltd's Short-Term Debt growth rate?
Short-Term Debt CAGR 5Y
70%

Over the last year, the Short-Term Debt growth was 153%. The average annual Short-Term Debt growth rates for Australian Pharmaceutical Industries Ltd have been 120% over the past three years , 70% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett